Rudolf de Boer

Rudolf de Boer (born 1972 in Gouda, Netherlands) is a Clinical Cardiologist and Full Professor of Translational Cardiology at the University of Groningen. He serves as the Director of Experimental Cardiology at the University Medical Center Groningen (UMCG) and holds leadership positions including President-elect of the Dutch Society of Cardiology (NVVC) and Liaison Officer of the ESC council on Cardio-oncology.

Professor de Boer completed his medical studies at the University of Groningen and pursued research fellowships at the University of Utah, University of Groningen, and Harvard Medical School. His educational background has positioned him at the forefront of translational cardiology research.

His research program focuses on cardiac remodeling and heart failure, fibrosis, diabetes, and cardio-oncology, with particular emphasis on connecting clinical observations to preclinical and mechanistic studies. Over recent years, his work has evolved to study biomarkers in clinical heart failure and the general population, examining their role in pathophysiology. His current research priorities center on the interaction between heart failure and comorbidities, especially cancer. His clinical interests include cardiogenetics, echocardiography, and end-stage heart failure management including VAD therapy and transplant.

The analysis of Professor de Boer's recent publications reveals a strong focus on clinical guidelines development, particularly through the European Society of Cardiology. His work spans heart failure therapeutics (especially SGLT2 inhibitors), cardio-oncology, telemonitoring applications, and biomarker research. There is a clear progression toward integrating metabolic perspectives in cardiovascular disease and developing multidisciplinary approaches to complex patient care.

• Fellow of the European Society of Cardiology (2010)
• VENI grant from Netherlands Heart Foundation (2009)
• VIDI grant from Dutch Organization for Scientific Research (2013)
• ERC consolidator grant (2019)
• Member of scientific committee of LifeLines population study
• President of Heart Failure Working Group of Dutch Society of Cardiology (2013-2019)
• Board member of Heart Failure Association of ESC (2014)

Professor de Boer has supervised 17 PhD students as first or second supervisor, with 7 currently working toward graduation. He has authored over 400 peer-reviewed articles and received numerous grants including from the Netherlands Heart Foundation, Dutch Organization for Scientific Research, and European Research Council. His editorial leadership includes serving as Associate Editor of the European Journal of Heart Failure (2009-2019) and current Associate Editor of the European Heart Journal (Heart Failure section).

He leads the Experimental Cardiology department at UMCG, which is closely integrated with the LifeLines population study involving 165,000 subjects. His research group maintains strong collaborations with international institutions and participates in major clinical trials and guideline development efforts through the European Society of Cardiology.